The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Bone Biologics Corp’s current trading price is -95.38% away from its 52-week high, while its distance from the 52-week low is 29.51%. The stock’s price range for this period has been between $0.47 and $13.20 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.22 million for the day, a number notably higher than the average daily volume of 1.01 million over the last three months.
The stock price for Bone Biologics Corp (BBLG) currently stands at $0.61. The stock experienced a substantial increase in the last session, hitting $0.61 after starting at $0.51. The stock’s lowest price was $0.47 before closing at $0.78.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Bone Biologics Corp saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $13.20 on 12/12/22, while the lowest price for the same duration was marked at $0.47 on 11/17/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bone Biologics Corp (BBLG) has experienced a quarterly decline of -24.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.91M and boasts a workforce of 2 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8765, with a change in price of -0.8900. Similarly, Bone Biologics Corp recorded 735,564 in trading volume during the last 100 days, posting a change of -59.33%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BBLG stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
BBLG Stock Stochastic Average
Bone Biologics Corp’s raw stochastic average for the past 50 days is presently 26.52%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 26.52%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 42.60% and 34.73%, respectively.
BBLG Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. This year’s metric has recorded a Price decrease of -90.30%. However, over the past six months, we’ve seen a stronger performance of -86.36%. The price of BBLG leaped by -0.81% over the last 30 days. And in the last five days, it has surged by 20.10%.
